Emerging data on SGLT2 benefits in acute coronary syndromes. [PDF]
Rawshani A.
europepmc +1 more source
Association of sodium-glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis. [PDF]
Maremmani M +7 more
europepmc +1 more source
Cardiovascular protection by SGLT2 inhibitors: an integrative review of mechanistic networks, clinical evidence, and safety considerations. [PDF]
Wang Z, Wang Y, Shangguan W, Li T.
europepmc +1 more source
Empagliflozin and Cardiovascular Outcomes: A Systematic Review of Randomized Controlled Trials in Populations With Diabetes and Heart Failure. [PDF]
Ansar F +10 more
europepmc +1 more source
The effect of sodium-glucose co-transporter 2 inhibitors on clinical outcomes after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Khan U +9 more
europepmc +1 more source
Administration of Sodium-Glucose Cotransporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review, Meta-Analysis, and Meta-Regression of Randomized Trials. [PDF]
Hariyanto TI, Vatvani AD, Yanto TA.
europepmc +1 more source
Effectiveness of SGLT2 inhibitors, incretin-based therapies, and finerenone on cardiorenal outcomes: a meta-analysis and network meta-analysis. [PDF]
Shokravi A, Seth J, Lu N, Mancini GBJ.
europepmc +1 more source
Sodium-Glucose Cotransporter 2 Inhibitors During Cancer Therapy: Benefits, Risks, and Ongoing Clinical Trials. [PDF]
Osataphan N +3 more
europepmc +1 more source
Conceptualization, development, and early dissemination of eMPACTTM: A competency-based career navigation system for translational research professionals. [PDF]
Choi I +7 more
europepmc +1 more source
Contemporary Management of Acute Coronary Syndromes in the Cardiac Intensive Care Unit: From Rapid Diagnosis to Early Secondary Prevention. [PDF]
Giamundo DM +10 more
europepmc +1 more source

